Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Ticker SymbolMGRX
Company nameMangoceuticals Inc
IPO dateMar 21, 2023
CEOMr. Jacob D. Cohen
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 21
Address15110 Dallas Pkwy, Suite 600
CityDALLAS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code75248
Phone18336264679
Websitehttps://www.mangorx.com/
Ticker SymbolMGRX
IPO dateMar 21, 2023
CEOMr. Jacob D. Cohen
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data